Variant report
Variant | nsv442915 |
---|---|
Chromosome Location | chr4:106942927-106946435 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr4:106943400-106943550 | GM12873 | blood: | n/a | n/a |
2 | CTCF | chr4:106945040-106945190 | GM12875 | blood: | n/a | n/a |
3 | MAFF | chr4:106945491-106945654 | HepG2 | liver: | n/a | chr4:106945610-106945628 |
4 | MAFK | chr4:106945487-106945756 | HepG2 | liver: | n/a | chr4:106945613-106945633 |
5 | MAFK | chr4:106945461-106945745 | HepG2 | liver: | n/a | chr4:106945613-106945633 |
6 | POLR2A | chr4:106944598-106944723 | GM12878 | blood: | n/a | n/a |
7 | RCOR1 | chr4:106942989-106943240 | K562 | blood: | n/a | n/a |
8 | TEAD4 | chr4:106942917-106943280 | K562 | blood: | n/a | n/a |
9 | TEAD4 | chr4:106942906-106943182 | K562 | blood: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TBCK-1 | chr4:106940966-106943635 | XLOC_004040 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249635 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570469510 | chr4:106942959-106942960 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs539377893 | chr4:106942964-106942965 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs371027795 | chr4:106943041-106943042 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs549369273 | chr4:106943145-106943146 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs11725254 | chr4:106943155-106943156 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs535735308 | chr4:106943194-106943195 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs11729561 | chr4:106943200-106943201 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs572575665 | chr4:106943243-106943244 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs534930922 | chr4:106943245-106943246 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs193251163 | chr4:106943257-106943258 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs570528756 | chr4:106943276-106943277 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs185332017 | chr4:106943333-106943334 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs534673363 | chr4:106943359-106943360 | Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs140736797 | chr4:106943429-106943430 | Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs574123684 | chr4:106943463-106943464 | Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs542130294 | chr4:106943469-106943470 | Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs561992502 | chr4:106943486-106943487 | Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs188975224 | chr4:106943496-106943497 | Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs570016678 | chr4:106943522-106943523 | Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs547282485 | chr4:106943533-106943534 | Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs564160968 | chr4:106943603-106943604 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs181381329 | chr4:106943617-106943618 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs532880202 | chr4:106943649-106943650 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553396299 | chr4:106943651-106943652 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144594038 | chr4:106943687-106943688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569293172 | chr4:106943720-106943721 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535107018 | chr4:106943804-106943805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184077968 | chr4:106943860-106943861 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566261070 | chr4:106943867-106943868 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535896726 | chr4:106943885-106943886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535181112 | chr4:106943946-106943947 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188418862 | chr4:106943979-106943980 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs578157527 | chr4:106943980-106943981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76774465 | chr4:106943981-106943982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557526386 | chr4:106943982-106943983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs180974109 | chr4:106944000-106944001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148186497 | chr4:106944016-106944017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561975425 | chr4:106944040-106944041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572254415 | chr4:106944062-106944063 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186063857 | chr4:106944081-106944082 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs28394440 | chr4:106944126-106944127 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs534883230 | chr4:106944213-106944214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192090002 | chr4:106944255-106944256 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372115881 | chr4:106944288-106944289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141159754 | chr4:106944305-106944306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182420813 | chr4:106944410-106944411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528825932 | chr4:106944475-106944476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535712897 | chr4:106944516-106944517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186291270 | chr4:106944523-106944524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs80116384 | chr4:106944581-106944582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
myeloid cancer | 21057493 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 22522925 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:106935000-106948400 | Weak transcription | Aorta | Aorta |
2 | chr4:106940400-106943000 | Enhancers | HSMMtube | muscle |
3 | chr4:106941000-106943200 | Enhancers | Fetal Heart | heart |
4 | chr4:106941000-106944000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
5 | chr4:106941200-106944400 | Enhancers | Primary hematopoietic stem cells | blood |
6 | chr4:106941400-106943800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr4:106942800-106943400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr4:106943000-106943800 | Enhancers | Left Ventricle | heart |
9 | chr4:106943000-106945400 | Weak transcription | Fetal Intestine Small | intestine |
10 | chr4:106943200-106943600 | Flanking Active TSS | Fetal Heart | heart |
11 | chr4:106943400-106944000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr4:106943600-106944400 | Enhancers | Fetal Heart | heart |
13 | chr4:106945400-106945600 | ZNF genes & repeats | Fetal Intestine Small | intestine |